Filing Details
Organon & Co. (NYSE:OGN) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event.
8k filedNYSE:OGN
Organon & Co. (OGN) Reports Material Event to SEC
Filing Details Organon & Co. (NYSE:OGN) filed a Form 8-K with the Securities and Exchange Commission on July 31, 2026, disclosing a material event. Market Context Organon & Co.'s…
Market Context
Organon & Co.'s stock currently trades at $13.55 with a market capitalization of $1.9B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Organon & Co.'s stock.
All SEC filings for Organon & Co. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View OGN Stock Page
Frequently Asked Questions
Where can I read OGN's SEC filings?
Browse all filings on our OGN SEC filings page.
What types of SEC filings does Organon & Co. file?
Public companies like Organon & Co. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.